“Hidradenitis suppurativa, also called acne inversa, is a chronic, debilitating skin disease characterized by painful, deep inflammatory lesions. These...
Archive for category: Clinical Trials
Infliximab (Remicade) performs better in all aspects than Humira (adalimumab) for severe recalcitrant Hidradentis Suppurativa using the Sartorius Scoring System, Clinical Trials, Research, Case Study, Diagnosis, Treatment, 0
Infliximab (Remicade) performs better in all aspects than Humira (adalimumab) for severe recalcitrant Hidradentis Suppurativa using the Sartorius Scoring...
A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS, Clinical Trials, Research, Dermatology, Treatment, 0
Drug: drospirenone and ethinyl estradiol (YAZ)|Drug: Placebo. Mean Improvement in the Sartorius Severity Score at Month 6.|Change From Baseline...
, Clinical Trials, Research, Treatment, 0
Biological: adalimumab|Biological: placebo. Percentage of Participants Achieving Hidradenitis Suppurativa Clinical Response (HiSCR) at Week 12|Percentage of Participants With Baseline...
HS Patient Stories
HS BOOK SERIES: “I WILL NOT HIDE” Hidradenitis suppurativa (HS)
Our series of book releases for #HSAWARENESS tell the stories of Hidradenitis Suppurativa (HS) patients in vivid and personal narrative. Told by the patients themselves.
” HS is a chronic skin disease with major impact on QoL even when compared to other dermatological diseases. MDI scores in HS patients correlate with disease severity. This correlation could indicate that the MDI represents a valid measure of disease related morbidity that may serve as an outcome measure in future studies and a relevant point of intervention for individual patients.”
— Ring HC, Theut Riis P, Miller IM, Saunte DM, Jemec GB